Our medicines Our science Our stories
Bristol Myers Squibb Skip to main content
Contact us Careers
United States

Americas

Argentina

Spanish

Brazil

Portuguese

Canada

English / French

Chile

Spanish

Colombia

Spanish

Mexico

Spanish

Peru

Spanish

United States

English

Asia Pacific

Australia

English

China

Simplified Chinese

India

English

Japan

Japanese

Korea

Korean

New Zealand

English

Singapore

English

Taiwan

Traditional Chinese

Thailand

English / Thai

Europe

Austria

German

Belgium

English / Dutch / French

Czech Republic

Czech

Denmark

Danish

Finland

Finnish

France

French

Germany

German

Greece

Greek

Hungary

Hungarian

Ireland

English

Italy

Italian

Luxembourg

English

Netherlands

English / Dutch

Norway

Norwegian

Poland

Polish

Portugal

Portuguese

Romania

Romanian

Spain

Spanish

Sweden

Swedish

Switzerland

German / French

United Kingdom

English

Middle East

Israel

Hebrew

Saudi Arabia

English / Arabic

Turkey

Turkish

United Arab Emirates

English / Arabic

Other

Other Markets

Distributor Markets
bmsUScqPageLucene
  • Medicines
  • Careers
  • Press Releases
  • Medical Information
Our Medicines

Patients & caregivers

Our medicines
Survivorship Today
Patient resources
Get help paying for your medicines
Risk evaluation and mitigation strategies (REMS)
Plain language summaries of clinical trial results
CAR T cell therapy patient resources

Related links

Immunology patient resources
Our position on generic drugs
Our position on drug pricing
Psoriasis around the world

Healthcare providers

Learn about pre-approval access
Learn about post study drug access
340B practice fact sheet

Related links

U.S. medical information
Clinical trials

Researchers

Areas of focus
In the pipeline
R&D expert voices
Our efforts in STEM
Clinical trials & research
Independent research
The Thomas O. Daniel research incubator and collaboration center
Patient safety

Related links

Research publications
Disclosure commitment
Areas of interest & research grants
Data sharing request process
Translational medicine

Investors

Stock information
Financial reporting
Analyst coverage
Events and presentations
Shareholder services
Acquisition-related information for Celgene shareholders
Investor contacts

Related links

Annual reports
Dividend history
Investment return calculator
SEC filings
Quarterly results

Business development

Our partnerships
Why partner with us
Areas of interest
Business development leadership team
Global alliances leadership team
Early innovation at BMS
Contact Business Development

Related links

Download business development brochure
Doing business with us as a supplier

News & media

Press releases
Our stories
Media library
Media contacts

Related links

Scientific media resources
Disease state resources
Corporate resources

About us

Our company
Leadership
Our science
Global Inclusion & Diversity
Our impact
Working at BMS
Contact us

Related links

Global Patient Week
Our technologies
Our history
Our locations
The Bristol Myers Squibb Foundation
Resource groups
Our positions

Our Stories

Idiopathic Pulmonary Fibrosis
News and reporting on pulmonary fibrosis�a lung disease that results from scarring of lung tissue�and treatments.
  • Advocacy
  • Atrial Fibrillation (AFib)
  • BMS Foundation
  • Blood & Bone Marrow Cancer
  • Blood Disorders
  • COVID-19
  • Cancer
  • Cancer Research
  • Cardiovascular Research
  • Careers
  • Clinical Trials
  • Collaboration
  • Decoded by BMS
  • Diversity
  • Diversity in clinical trials
  • Employee Stories
  • Global Inclusion and Diversity
  • Health Equity
  • Her Perspective
  • Idiopathic Pulmonary Fibrosis
  • Immune-mediated
  • Immunotherapy
  • Inclusion and Engagement
  • International
  • Leadership Perspectives
  • Lung Cancer
  • Lymphoma
  • Neuroscience
  • Our Culture
  • Pancreatic Cancer
  • Patient Advocacy
  • Patient Perspectives
  • Philanthropy
  • Protein Degradation
  • Research and Development
  • Rheumatoid Arthritis (RA)
  • STEM
  • Science & Innovation
  • Science Firsthand
  • Sustainability
  • Volunteerism
Breathing new hope into pulmonary fibrosis research care
May 07, 2025
Breathing new hope into pulmonary fibrosis research care

Main navigation

  • Sitemap
  • Home
  • Patients & caregivers
  • Healthcare providers
  • Researchers
  • Investors
  • News & media
  • About us

Resources

  • Our medicines
  • Legal notice
  • Privacy notice center
  • Trademarks
  • Forward-looking statement
  • BMS Modern Slavery Statement (PDF)

Follow us

  • Facebook
  • Instagram
  • X
  • LinkedIn
  • YouTube
  • Careers
  • Our stories
  • Contact us
  • Worldwide locations
August 22, 2024
© 2025 Bristol-Myers Squibb Company